Elephant calves first in Australia to be vaccinated against deadly virus: news

Elephant Calves First in Australia to Be Vaccinated Against Deadly EEHV Virus

Young Asian elephant calves at Werribee Open Range Zoo in Victoria have become the first in Australia to be vaccinated against Elephant Endotheliotropic Herpesvirus (EEHV), marking a significant milestone in global elephant conservation and wildlife veterinary medicine.

Understanding the EEHV Threat to Asian Elephants

EEHV is an acute, life-threatening viral pathogen primarily affecting young Asian elephants between one and eight years of age. The virus attacks endothelial cells, leading to massive internal hemorrhaging, fluid accumulation, and severe systemic collapse. With a mortality rate reaching up to 85% in symptomatic juvenile cases, EEHV represents the single greatest medical threat to the survival of young captive and wild Asian elephants worldwide.

The Breakthrough Vaccine Rollout

Veterinary teams and conservation scientists administered the experimental multi-antigen vaccine trial to bolster immunity in high-risk calves before natural exposure triggers hemorrhagic disease.

Key aspects of the immunization program include:

• Targeted Immune Response: The vaccine is engineered to stimulate antibodies and T-cell responses against dominant lethal strains, notably EEHV1A.

• Preventative Protection: Rather than relying solely on post-infection antiviral interventions and plasma transfusions, vaccination aims to stop severe clinical disease before lethal hemorrhaging begins.

  Baylor College of Medicine Blog Network –

• Conservation Impact: The Australian trial provides essential immunological data that supports international captive breeding programs and future protection initiatives for wild herds across Southeast Asia.

This veterinary milestone offers long-term hope for preserving the endangered Asian elephant population against one of nature’s most aggressive wildlife viruses.